Resistance to ceftazidime–avibactam and other new β-lactams in Pseudomonas aeruginosa clinical isolates: a multi-center surveillance study

ABSTRACT New β-lactam–β-lactamase inhibitor combinations represent last-resort antibiotics to treat infections caused by multidrug-resistant Pseudomonas aeruginosa. Carbapenemase gene acquisition can limit their spectrum of activity, and reports of resistance toward these new molecules are increasin...

Full description

Bibliographic Details

Published in:	Microbiology Spectrum
Main Authors:	Felice Valzano, Gianfranco La Bella, Teresa Lopizzo, Anna Curci, Laura Lupo, Elisabetta Morelli, Adriana Mosca, Marianna Marangi, Raffaela Melfitano, Tiziana Rollo, Rosella De Nittis, Fabio Arena
Format:	Article
Language:	English
Published:	American Society for Microbiology 2024-08-01
Subjects:	Pseudomonas aeruginosa ceftazidime-avibactam β-lactamases clonal diversity Southern Italy
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.04266-23